This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jenkins, P. J. Articles by Besser, G. M. Search for Related Content PubMed PubMed Citation Articles by Jenkins, P. J. Articles by Besser, G. M.

Insulin-Like Growth Factor I and the Development of Colorectal Neoplasia in Acromegaly¹

Departments of Endocrinology (P.J.J., V.F., A.-M.J., C.C.-H., S.L.C., A.B.G., J.P.M., G.M.B.), Histopathology (D.G.L.), and Gastroenterology (P.D.F.), St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom

Address correspondence and requests for reprints to: Dr. Paul Jenkins, Department of Endocrinology, St. Bartholomew’s Hospital, West Smithfield, London EC1A 7BE, United Kingdom. E-mail: P.J.Jenkins{at}mds.qmw.ac.uk

Patients with acromegaly are at increased risk of colorectal neoplasia and, by analogy with high-risk nonacromegalic patients, may require regular colonoscopic screening. However, it is unknown whether the risk is equal in all patients or whether some should be regarded as carrying a particularly high risk. The aims of this study were: 1) to establish the natural history of colorectal neoplasia in acromegaly; 2) to establish which patients are at increased risk of developing neoplasia; and 3) to elucidate the influence of insulin-like growth factor I (IGF-I) in adenoma formation. A prospective colonoscopic evaluation of the development of new premalignant adenomas in the colon was performed in 66 patients with biochemically proven acromegaly who had previously undergone colonoscopic screening and removal of all visible polyps. Twenty-five patients (38%) had a total of 37 polyps detected at the second colonoscopy: nine (14%) had at least one adenoma, and 18 (27%) had one or more hyperplastic polyps (2 patients had both). The development of new adenomas, but not hyperplastic polyps, was associated both with elevated serum IGF-I (P < 0.005) and, to a lesser extent, with a previous adenoma at the original colonoscopy (P < 0.07). In summary, patients with acromegaly and in whom serum IGF-I remains elevated and/or who have had a previous adenoma should be regarded as having an especially high risk for the development of subsequent colorectal neoplasia. Serum IGF-I seems to be implicated in the development of colorectal neoplasia in acromegaly, although the exact mechanisms remain uncertain.

This article has been cited by other articles:

				E. Resmini, A. Tagliafico, L. Bacigalupo, G. Giordano, E. Melani, A. Rebora, F. Minuto, G. A. Rollandi, and D. Ferone Computed Tomography Colonography in Acromegaly J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 218 - 222. [Abstract] [Full Text] [PDF]

				E. T. Jacobs, M. E. Martinez, D. S. Alberts, E. L. Ashbeck, S. M. Gapstur, P. Lance, and P. A. Thompson Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 300 - 305. [Abstract] [Full Text] [PDF]

				A. Colao, R. Pivonello, R. S. Auriemma, M. Galdiero, D. Ferone, F. Minuto, P. Marzullo, and G. Lombardi The Association of Fasting Insulin Concentrations and Colonic Neoplasms in Acromegaly: A Colonoscopy-Based Study in 210 Patients J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3854 - 3860. [Abstract] [Full Text] [PDF]

				F. Bogazzi, C. Cosci, C. Sardella, A. Costa, L. Manetti, M. Gasperi, G. Rossi, L. Bartalena, and E. Martino Identification of Acromegalic Patients at Risk of Developing Colonic Adenomas J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1351 - 1356. [Abstract] [Full Text] [PDF]

				T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081. [Abstract] [Full Text] [PDF]

				M. Terzolo, G. Reimondo, M. Gasperi, R. Cozzi, R. Pivonello, G. Vitale, A. Scillitani, R. Attanasio, E. Cecconi, F. Daffara, et al. Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 84 - 90. [Abstract] [Full Text] [PDF]

				F. Bogazzi, F. Ultimieri, F. Raggi, D. Russo, R. Vanacore, C. Guida, S. Brogioni, C. Cosci, M. Gasperi, L. Bartalena, et al. Growth Hormone Inhibits Apoptosis in Human Colonic Cancer Cell Lines: Antagonistic Effects of Peroxisome Proliferator Activated Receptor-{gamma} Ligands Endocrinology, July 1, 2004; 145(7): 3353 - 3362. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				F. Bogazzi, F. Ultimieri, F. Raggi, D. Russo, P. Viacava, D. Cecchetti, A. Costa, S. Brogioni, C. Cosci, M. Gasperi, et al. Changes in the Expression of the Peroxisome Proliferator-Activated Receptor {gamma} Gene in the Colonic Polyps and Colonic Mucosa of Acromegalic Patients J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3938 - 3942. [Abstract] [Full Text] [PDF]

				A G Renehan, S T O'Dwyer, S M Shalet, P J Jenkins, and P D Fairclough Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other high risk groups Gut, July 1, 2003; 52(7): 1071 - 1072. [Full Text]

				P J Jenkins and P D Fairclough Screening guidelines for colorectal cancer and polyps in patients with acromegaly Gut, October 1, 2002; 51(90005): v13 - 14. [Full Text] [PDF]

				M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980. [Abstract] [Full Text] [PDF]

				R Palmqvist, G Hallmans, S Rinaldi, C Biessy, R Stenling, E Riboli, and R Kaaks Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden Gut, May 1, 2002; 50(5): 642 - 646. [Abstract] [Full Text] [PDF]

				L. Le Marchand, T. Donlon, A. Seifried, R. Kaaks, S. Rinaldi, and L. R. Wilkens Association of a Common Polymorphism in the Human GH1 Gene with Colorectal Neoplasia J Natl Cancer Inst, March 20, 2002; 94(6): 454 - 460. [Abstract] [Full Text] [PDF]

				A. B. Hassan and V. M. Macaulay The insulin-like growth factor system as a therapeutic target in colorectal cancer Ann. Onc., March 1, 2002; 13(3): 349 - 356. [Abstract] [Full Text] [PDF]

				S. Melmed CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2929 - 2934. [Full Text] [PDF]

				P. J. Jenkins and M. Besser CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2935 - 2941. [Full Text] [PDF]